Research
Hormonal
GLP-1 receptor agonists have beneficial effects on atherosclerosis and cardiovascular disease.
Practitioners may consider GLP-1 receptor agonists as a treatment option for improving cardiovascular health in patients with obesity and type 2 diabetes.
StrongSupportsmedium confidence
The aim of this review is to summarize available preclinical and clinical data on the beneficial effects of GLP-1 receptor agonists on atherosclerosis and cardiovascular disease.
Why this rating
The claim is based on a review of preclinical and clinical data.
Source
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action
Κλεοπάτρα Αλεξιάδου et al. · Trends in Cardiovascular Medicine · 2024
reviewCited 23×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →